Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

First UK Patient Enrolled into Luminous™ Programme – Novartis' 30,000 Patient Observational Study in Ophthalmology

August 21, 2011 11:41 pm | by RealWire | News | Comments

Luminous, launched today, will provide long-term effectiveness, safety, and patient reported outcome data on Lucentis® (ranibizumab) in 30,000 patients in real-life settings across the worldFrimley, August 22 2011 - Novartis Pharmaceuticals UK Ltd (Novartis) has announced the...

The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977

August 19, 2011 5:45 pm | by Bio-Medicine.Org | News | Comments

WHITE PLAINS, N.Y., Aug. 19, 2011 /- Today the Food and Drug Administration (FDA) approved Seattle Genetics' Adcetris to treat two types of rare blood cancers – Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO)...

Tips for Reducing the Signs of Arthritis in Pets

August 18, 2011 11:42 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Aug. 18, 2011 /- According to the Arthritis Foundation, arthritis affects one in every five adult dogs in the United States and is one of the most common sources of chronic pain that veterinarians treat. Pet owners can easily be overwhelmed by the variety of...

Advertisement

Polymedco Announces Publication in Epidemiologic Reviews

August 17, 2011 9:42 am | by Bio-Medicine.Org | News | Comments

CORTLANDT MANOR, N.Y., Aug. 17, 2011 /- Polymedco is pleased to announce a publication in Epidemiologic Review, "Organized Colorectal Cancer Screening in Integrated Health Care Systems" by Theodore R Levin, Laura Jamieson, Daniel A Burley, Juan Reyes, Michael Oehrli, and Cindy Caldwell...

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's Genousâ„¢ Stent in Patients at High Risk for Restenosis

August 16, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Aug. 16, 2011 /- OrbusNeich today announced that the that the company's Genous Stent showed no significant difference in the rate of target vessel failure (TVF) at two years compared to the Taxus Liberte™ paclitaxel-eluting stent in patients with de novo coronary artery...

CR Magazine Congratulates Cynthia Ryan, Ph.D., Clarion Award Recipient

August 16, 2011 6:40 am | by AACR | News | Comments

Tweet PHILADELPHIA — CR magazine, the AACR’s magazine for cancer survivors, their families and caregivers, congratulates contributing writer Cynthia Ryan, Ph.D., on her Clarion Award-winning article, “Homeless With Cancer,” which was published in CR’s Fall...

New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses

August 16, 2011 2:43 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Aug. 16, 2011 /- Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function. The study found that MCP activated B-cells in a dose-dependent manner, and induced a highly significant...

THA Group Partners with Cardiocom Telehealth

August 15, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Aug. 15, 2011 /- THA Group, a free standing in-home health company serving coastal Georgia and South Carolina, announced that it will be partnering with Cardiocom® to expand its chronic telehealth program providing advanced home telehealth technology to patients with...

Advertisement

HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference

August 12, 2011 10:45 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass and SYDNEY, Aug. 12, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug...

University Hospitals and Centerre Healthcare Announce Joint Venture to Open Comprehensive Inpatient Rehabilitation Hospital

August 12, 2011 7:42 am | by Bio-Medicine.Org | News | Comments

CLEVELAND and NASHVILLE, Tenn., Aug. 12, 2011 /- University Hospitals (UH) in Cleveland, OH, and Nashville-based Centerre Healthcare Corporation announced today a joint venture to construct a comprehensive inpatient rehabilitation hospital in Beachwood, OH. Scheduled for completion in...

Newly-Published Colchicine Safety Data Provide First Evidence-Based Dosing Guidance to Avoid Potentially Serious Interactions With Commonly Prescribed Drugs

August 11, 2011 12:39 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Aug. 11, 2011 /- Newly-published results from a series of colchicine safety studies provide physicians with the first evidence-based dosing guidance for colchicine when co-administered with certain commonly prescribed drugs, helping doctors and patients avoid serious and...

Dentists, Pharmacists Raise Awareness of Medication-Induced Dry Mouth

August 11, 2011 9:42 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Aug. 11, 2011 /PRNewswire-USNewswire/ -- Leading dental and pharmacy organizations are teaming up to promote oral health and raise public awareness of dry mouth, a side effect commonly caused by taking prescription and over-the-counter medications.  More than 500 medications...

Althea Technologies Hosts Health and Wellness Week

August 11, 2011 3:44 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 11, 2011 /- Althea Technologies, Inc., a leading provider of development and manufacturing services for biotechnology and pharmaceutical companies, held its inaugural Health and Wellness Fair today. The fair is part of a weeklong wellness program, which includes daily...

Advertisement

Cook Medical's Doppler Blood Flow Monitor a Significant Advance for Free Flap Procedures

August 10, 2011 10:47 am | News | Comments

Technology leverages company's patented Doppler platform, providing surgeons with a direct vessel monitoring tool to assist in transplant and reconstructive surgeries

AACR Mourns the Loss of Two Champions of Biomedical Research

August 10, 2011 7:41 am | by AACR | News | Comments

Tweet PHILADELPHIA — The American Association for Cancer Research is deeply saddened by the loss of former National Institutes of Health (NIH) Director Bernadine P. Healy, M.D., and former Sen. Mark O. Hatfield, two distinguished leaders who separately championed the promise of...

Aprima and Health Care Strategies Join Forces to Improve the Financial Health of Physicians

August 10, 2011 7:41 am | by Bio-Medicine.Org | News | Comments

DALLAS, Aug. 10, 2011 /- Aprima Medical Software announced today the acquisition of Health Care Strategies (HCS), a leading provider of Revenue Cycle Management (RCM) services to physician offices throughout the U.S. HCS has consistently achieved significant gains in receivables...

GNS Healthcare Announces Collaboration With Bristol-Myers Squibb

August 10, 2011 7:41 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Aug. 10, 2011 /- GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Bristol-Myers Squibb Company (NYSE: BMY ) focused on the...

Premier Awards Sixth Consecutive Contract to Instrumentation Laboratory for Critical Care Portfolio

August 10, 2011 7:41 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Aug. 10, 2011 /- Instrumentation Laboratory (IL) today announced that it has been awarded a three-year contract for its critical care portfolio with Premier Purchasing Partners, the group purchasing organization of the Premier healthcare alliance.  This is the sixth...

UK's 1st Total Artificial Heart Patient Discharged Home Using Freedom® Portable Driver

August 10, 2011 7:41 am | by Bio-Medicine.Org | News | Comments

TUCSON, Ariz., Aug. 10, 2011 /- SynCardia Systems, Inc. ( www.syncardia.com ), manufacturer of the SynCardia temporary Total Artificial Heart , announced today that on Aug. 2, Papworth Hospital in Cambridge discharged the United Kingdom's first Total Artificial Heart patient to wait for a...

Affordable Healthcare Electronics Effects in the Long Term

August 9, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Aug. 9, 2011 /PRNewswire-Asia/ -- In the 55th international medical devices exhibition held in Shenzhen Exhibition Centre, a great variety of healthcare products are striving to enter into personal families. Compared with large medical equipment exhibited in only one...

Medical Equipment Quarterly Deals Analysis: M & A and Investment Trends - Q2 2011

August 9, 2011 4:40 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011...

HeartWare to Present at the Canaccord Genuity 31st Annual Growth Conference

August 8, 2011 11:42 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass. and SYDNEY, Aug. 8, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug...

Spaulding Clinical Announces New Joint Partnership for Global Studies with Eurofins Optimed Clinical Research

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., Aug. 8, 2011 /- Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint...

Carrot Medical Positioned for Third Straight Year of Triple Digit Growth

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

BOSTON, Aug. 8, 2011 /- Carrot Medical, a leading manufacturer of integrated medical imaging display and communication systems, has announced results for Q2 2011. During the year, Carrot Medical achieved significant growth in sales and an expansion of sales channels. Concluding the first...

Cardica to Present at the Wedbush Life Sciences Management Access Conference

August 8, 2011 5:39 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Aug. 8, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and chief executive officer, is scheduled to present a corporate overview and update at the Wedbush 2011 Life Sciences Management Access...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading